NPY and colorectal carcinoma: Neuropeptide Y (NPY) expression is observed to be lower in patients who have developed liver metastasis (CRC-LM), which is consistent with the observation that NPY-ergic neurons are reduced in CRC-LM cases compared with healthy livers [30].